Cleared Traditional

K072260 - NUFACE, MODEL NU-4003

K072260 is an FDA 510(k) clearance for NUFACE, manufactured by Carol Cole Company. The device is a Class 2 Neurology device with product code NFO cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K072260 · Carol Cole Company · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
105d
Days
Class 2
Risk

K072260 is an FDA 510(k) clearance for the NUFACE, MODEL NU-4003. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Carol Cole Company (La Jolla, US). The FDA issued a Cleared decision on November 27, 2007 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K072260

510(k) Number K072260 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2007
Decision Date November 27, 2007
Days to Decision 105 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 149d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFO Device Classification - Class 2, Special Controls

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 80
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K072260.
RUGALIFT, MODEL# V.2.1
K071573 · Fatrotek S.R.L. · Dec 2008
NUTRITONE FACIAL BEAUTY SYSTEM
K070250 · Isomers Laboratories, Inc. · Sep 2008
INTERX 1000/DERMA 200 STIMULATOR FOR COSMETIC USE
K070217 · Neuro Resource Group, Inc. · Apr 2008
FACEMASTER FACIAL TONING SYSTEM
K040871 · Facemaster of Beverly Hills, Inc. · Jun 2005
REJUVENIQUE MODEL #RJV10
K011935 · Salton, Inc. · Aug 2001